Action monitoring and depressive symptom reduction in major depressive disorder

被引:83
|
作者
Schrijvers, Didier [1 ]
De Bruijn, Ellen R. A. [1 ,2 ]
Maas, Yvonne J. [2 ]
Vancoillie, Patrick [3 ]
Hulstijn, Wouter [1 ,2 ]
Sabbe, Bernard G. C. [1 ,3 ]
机构
[1] Univ Antwerp, Fac Med, CAPRI, B-2610 Antwerp, Belgium
[2] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HE Nijmegen, Netherlands
[3] Psychiat Hosp Sint Norbertus, B-2570 Duffel, Belgium
关键词
Action monitoring; Error positivity; Error-related negativity; Major depression; Anterior cingulate cortex; ERN; Ne; Pe; EVENT-RELATED POTENTIALS; ERROR-DETECTION; HEALTHY-VOLUNTEERS; ERP COMPONENTS; BRAIN ACTIVITY; NEURAL SYSTEM; RETARDATION; COMPENSATION; FLUOXETINE; ANXIETY;
D O I
10.1016/j.ijpsycho.2008.09.005
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Introduction: Action monitoring has been reported to be disturbed in Major Depressive Disorder (MDD). Well-known markers for this action monitoring process are the error negativity/error-related negativity (Ne/ERN) and error positivity (Pe), both event-related potentials (ERP) generated in the anterior cingulate cortex. This study aims to explore the impact of symptom severity reduction on the Ne/ERN and Pe in MDD. Methods: Behavioural and ERP measurements were obtained in 15 MDD patients during performance on a speeded flankers task during the early stages of a depressive episode and compared with those recorded after 7 weeks of treatment. The same schedule was Used in 15 healthy controls. Results: Whereas overall Ne/ERN and Pe peak amplitudes did not improve front sessions 1 to 2 in the patients, positive correlations emerged between between-session changes in symptom severity and Ne/ERN amplitudes. No such correlations were observed for the Pe. ERP amplitudes in the controls also remained unchanged between both sessions. Significant group differences were observed between MDD patients and controls for the Pe, but not for the Ne/ERN. Conclusions: Whereas a clear association was observed between the level of symptom reduction and the level of improvement in Ne/ERN amplitudes in a MDD sample, no overall Ne/ERN enhancements were observed during symptom remission. Subsequent research is needed to further investigate the possible impact of depressive symptom reduction on the action monitoring in MDD. Several factors that might explain the absence of Ne/ERN group differences between patients and healthy controls in the current sample will also be discussed. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:218 / 224
页数:7
相关论文
共 50 条
  • [41] Accuracy of automated classification of major depressive disorder as a function of symptom severity
    Ramasubbu, Rajamannar
    Brown, Matthew R. G.
    Cortese, Filmeno
    Gaxiola, Ismael
    Goodyear, Bradley
    Greenshaw, Andrew J.
    Dursun, Serdar M.
    Greiner, Russell
    NEUROIMAGE-CLINICAL, 2016, 12 : 320 - 331
  • [42] Patterns of activity correlate with symptom severity in major depressive disorder patients
    S. Spulber
    F. Elberling
    J. Svensson
    M. Tiger
    S. Ceccatelli
    J. Lundberg
    Translational Psychiatry, 12
  • [43] A Simple Platelet Biomarker is Associated With Symptom Severity in Major Depressive Disorder
    Targum, Steven
    Gunay, Aksu
    Ajilore, Olusola
    Leow, Alex
    Rasenick, Mark
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 117 - 117
  • [44] Genetic polymorphisms in the serotonergic system and symptom clusters of major depressive disorder
    Kamata, Mitsuhiro
    Suzuki, Akihito
    Yoshida, Keizo
    Takahashi, Hitoshi
    Higuchi, Hisashi
    Otani, Koichi
    JOURNAL OF AFFECTIVE DISORDERS, 2011, 135 (1-3) : 374 - 376
  • [45] A simple platelet biomarker is associated with symptom severity in major depressive disorder
    Gunay, Aksu
    Targum, Steven D.
    Leow, Alex D.
    Ajilore, Olusola
    Rasenick, Mark M.
    MOLECULAR PSYCHIATRY, 2025,
  • [46] Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder
    Papakostas, George I.
    Petersen, Timothy
    Sklarsky, Katherine G.
    Nierenberg, Andrew A.
    Alpert, Jonathan E.
    Fava, Maurizio
    PSYCHIATRY RESEARCH, 2007, 149 (1-3) : 195 - 200
  • [47] Timing of clinical improvement and symptom resolution in the treatment of Major Depressive Disorder
    Papakostas, GI
    Alpert, JE
    Nierenberg, AA
    Fava, M
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S161 - S161
  • [48] Patterns of activity correlate with symptom severity in major depressive disorder patients
    Spulber, S.
    Elberling, F.
    Svensson, J.
    Tiger, M.
    Ceccatelli, S.
    Lundberg, J.
    TRANSLATIONAL PSYCHIATRY, 2022, 12 (01)
  • [49] Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder
    Altshuler, Lori L.
    Abulseoud, Osama A.
    Foland-Ross, Lara
    Bartzokis, George
    Chang, Sean
    Mintz, Jim
    Hellemann, Gerhard
    Vinters, Harry V.
    BIPOLAR DISORDERS, 2010, 12 (05) : 541 - 549
  • [50] Subcortical volumes differentiate Major Depressive Disorder, Bipolar Disorder, and remitted Major Depressive Disorder
    Sacchet, Matthew D.
    Livermore, Emily E.
    Iglesias, Juan Eugenio
    Glover, Gary H.
    Gotlib, Ian H.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2015, 68 : 91 - 98